Covering one packed agenda, four interventions and six hectic days, EIA campaigners share the highlights of the 78th meeting of the Standing Committee (SC78) of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) in Geneva. Elephants Asian elephants SC78 marked EIA’s first engagement at CITES on the […]
This year is a big one for the Convention on International Trade in Endangered Species (CITES), with the 78th meeting of the Standing Committee (SC78) kicking off in Geneva, Switzerland from 3-8 February. This will be followed by the much larger 20th Conference of the Parties (CoP20) in Samarkand, Uzbekistan later in the year. EIA […]
A new species of pangolin has been discovered, but already it is deemed to be threatened by illegal trade. The Indo-Burmese pangolin (Manis indoburmanica ) is the tenth to be found and was identified by scientists who were conducting routine examination of pangolin scales seized in India. Some of these scales were identified as coming from […]
The Government of China has made a commitment (Chinese) to supporting the development of substitutes for endangered wildlife used in traditional Chinese medicine (TCM). The announcement by the National Medical Products Administration of China (NMPA) is an encouraging step towards ending the use of threatened wildlife in TCM and represents tangible progress following a proposal […]
EIA has joined with more than 245 civil society organisations from at least 42 countries to call on the European Parliament and national EU governments to reject the European Commission’s bid to stall a major forests protection law. The Commission is proposing a delay of 12 months to legally applying the EU Deforestation Regulation (EUDR). […]
Norges Bank has divested from a major traditional Chinese medicine (TCM) company in the wake of EIA’s major exposé Investing in Extinction, which found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 products. The bank cited an ‘unacceptable risk’ of Tianjin Pharmaceutical Da Re Tang Group Corp […]